CASP3 and neoplasm: Analysis of the tumor proliferative index in the temsirolimus-treated tumor samples confirmed a decrease in proliferative rate, as indicated by reduced Ki67 staining, with an associated increase in apoptosis (increased cleaved caspase 3) in both short-term and long-term treated tumors (Fig. 4d).